1h Free Analyst Time
The global oral biologics market is forecasted to grow by USD 11.13 billion during 2025-2030, accelerating at a CAGR of 21.1% during the forecast period. The report on the global oral biologics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological innovations in drug delivery systems and encapsulation protocols, high patient demand for non-invasive therapies in chronic disease management, escalating strategic alliances, licensing deals, and venture investments.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global oral biologics market is segmented as below:
By Type
- GLP-1 receptor agonists
- Hormones
- Recombinant enzymes
- Somatostatin analogues
- Others
By Product Type
- Tablets
- Capsules
- Syrups
- Oral powders
- Others
By Distribution Channel
- Retail pharmacies
- Hospital pharmacies
- Online pharmacies
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Russia
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
The report on the global oral biologics market covers the following areas:
- Global oral biologics market sizing
- Global oral biologics market forecast
- Global oral biologics market industry analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Oral Biologics Market 2020 - 2024
- Historic Market Size - Data Table on Global Oral Biologics Market 2020 - 2024 ($ million)
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Oral Biologics Market
6.2 Impact of geopolitical conflicts on Global Oral Biologics Market
6.2 Impact of geopolitical conflicts on Global Oral Biologics Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Type
8.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on GLP-1 receptor agonists - Market size and forecast 2025-2030 ($ million)
- Data Table on GLP-1 receptor agonists - Market size and forecast 2025-2030 ($ million)
- Chart on GLP-1 receptor agonists - Year-over-year growth 2025-2030 (%)
- Data Table on GLP-1 receptor agonists - Year-over-year growth 2025-2030 (%)
- Chart on Hormones - Market size and forecast 2025-2030 ($ million)
- Data Table on Hormones - Market size and forecast 2025-2030 ($ million)
- Chart on Hormones - Year-over-year growth 2025-2030 (%)
- Data Table on Hormones - Year-over-year growth 2025-2030 (%)
- Chart on Recombinant enzymes - Market size and forecast 2025-2030 ($ million)
- Data Table on Recombinant enzymes - Market size and forecast 2025-2030 ($ million)
- Chart on Recombinant enzymes - Year-over-year growth 2025-2030 (%)
- Data Table on Recombinant enzymes - Year-over-year growth 2025-2030 (%)
- Chart on Somatostatin analogues - Market size and forecast 2025-2030 ($ million)
- Data Table on Somatostatin analogues - Market size and forecast 2025-2030 ($ million)
- Chart on Somatostatin analogues - Year-over-year growth 2025-2030 (%)
- Data Table on Somatostatin analogues - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Product Type
9.1 Market segments
- Chart on Product Type - Market share 2025-2030 (%)
- Data Table on Product Type - Market share 2025-2030 (%)
- Chart on Comparison by Product Type
- Data Table on Comparison by Product Type
- Chart on Tablets - Market size and forecast 2025-2030 ($ million)
- Data Table on Tablets - Market size and forecast 2025-2030 ($ million)
- Chart on Tablets - Year-over-year growth 2025-2030 (%)
- Data Table on Tablets - Year-over-year growth 2025-2030 (%)
- Chart on Capsules - Market size and forecast 2025-2030 ($ million)
- Data Table on Capsules - Market size and forecast 2025-2030 ($ million)
- Chart on Capsules - Year-over-year growth 2025-2030 (%)
- Data Table on Capsules - Year-over-year growth 2025-2030 (%)
- Chart on Syrups - Market size and forecast 2025-2030 ($ million)
- Data Table on Syrups - Market size and forecast 2025-2030 ($ million)
- Chart on Syrups - Year-over-year growth 2025-2030 (%)
- Data Table on Syrups - Year-over-year growth 2025-2030 (%)
- Chart on Oral powders - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral powders - Market size and forecast 2025-2030 ($ million)
- Chart on Oral powders - Year-over-year growth 2025-2030 (%)
- Data Table on Oral powders - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Product Type ($ million)
- Data Table on Market opportunity by Product Type ($ million)
10 Market Segmentation by Distribution Channel
10.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Russia - Market size and forecast 2025-2030 ($ million)
- Data Table on Russia - Market size and forecast 2025-2030 ($ million)
- Chart on Russia - Year-over-year growth 2025-2030 (%)
- Data Table on Russia - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Taiwan - Market size and forecast 2025-2030 ($ million)
- Data Table on Taiwan - Market size and forecast 2025-2030 ($ million)
- Chart on Taiwan - Year-over-year growth 2025-2030 (%)
- Data Table on Taiwan - Year-over-year growth 2025-2030 (%)
- Chart on Singapore - Market size and forecast 2025-2030 ($ million)
- Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
- Chart on Singapore - Year-over-year growth 2025-2030 (%)
- Data Table on Singapore - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Australia - Market size and forecast 2025-2030 ($ million)
- Data Table on Australia - Market size and forecast 2025-2030 ($ million)
- Chart on Australia - Year-over-year growth 2025-2030 (%)
- Data Table on Australia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Technological innovations in drug delivery systems and encapsulation protocols
- High patient demand for non-invasive therapies in chronic disease management
- Escalating strategic alliances, licensing deals, and venture investments
- Biological and enzymatic barriers to bioavailability in gastrointestinal tract
- High manufacturing complexity and scalability constraints
- Complex regulatory pathways and commercial pricing pressures
- Impact of drivers and challenges in 2025 and 2030
- Technological breakthroughs in oral drug delivery systems and advanced bioavailability formulations
- Rising global prevalence of chronic diseases and demand for patient-centric oral therapies
- Strategic alliances, robust clinical pipelines, and favorable regulatory support
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Segment focus
- SWOT
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key news
- Astellas Pharma Inc. - Key offerings
- SWOT
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Business segments
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- AstraZeneca Plc - Segment focus
- SWOT
- Bachem AG - Overview
- Bachem AG - Business segments
- Bachem AG - Key news
- Bachem AG - Key offerings
- Bachem AG - Segment focus
- SWOT
- Biocatalysts Ltd. - Overview
- Biocatalysts Ltd. - Product / Service
- Biocatalysts Ltd. - Key offerings
- SWOT
- Catalent Inc. - Overview
- Catalent Inc. - Product / Service
- Catalent Inc. - Key offerings
- SWOT
- Colorcon Inc. - Overview
- Colorcon Inc. - Product / Service
- Colorcon Inc. - Key offerings
- SWOT
- Corden Pharma Intl. GmbH - Overview
- Corden Pharma Intl. GmbH - Product / Service
- Corden Pharma Intl. GmbH - Key offerings
- SWOT
- Evonik Industries AG - Overview
- Evonik Industries AG - Business segments
- Evonik Industries AG - Key news
- Evonik Industries AG - Key offerings
- Evonik Industries AG - Segment focus
- SWOT
- Ironwood Pharmaceuticals Inc. - Overview
- Ironwood Pharmaceuticals Inc. - Product / Service
- Ironwood Pharmaceuticals Inc. - Key offerings
- SWOT
- Lonza Group Ltd. - Overview
- Lonza Group Ltd. - Business segments
- Lonza Group Ltd. - Key news
- Lonza Group Ltd. - Key offerings
- Lonza Group Ltd. - Segment focus
- SWOT
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Segment focus
- SWOT
- Novozymes AS - Overview
- Novozymes AS - Product / Service
- Novozymes AS - Key offerings
- SWOT
- PolyPeptide Group - Overview
- PolyPeptide Group - Product / Service
- PolyPeptide Group - Key offerings
- SWOT
- Roquette Freres SA - Overview
- Roquette Freres SA - Product / Service
- Roquette Freres SA - Key offerings
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Product Type
Exhibit 7: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Oral Biologics Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Type - Market share 2025-2030 (%)
Exhibit 39: Data Table on Type - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Type
Exhibit 41: Data Table on Comparison by Type
Exhibit 42: Chart on GLP-1 receptor agonists - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on GLP-1 receptor agonists - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on GLP-1 receptor agonists - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on GLP-1 receptor agonists - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Hormones - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Hormones - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Hormones - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Hormones - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Recombinant enzymes - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Recombinant enzymes - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Recombinant enzymes - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Recombinant enzymes - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Somatostatin analogues - Market size and forecast 2025-2030 ($ million)
Exhibit 55: Data Table on Somatostatin analogues - Market size and forecast 2025-2030 ($ million)
Exhibit 56: Chart on Somatostatin analogues - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Somatostatin analogues - Year-over-year growth 2025-2030 (%)
Exhibit 58: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 59: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 60: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 62: Market opportunity by Type ($ million)
Exhibit 63: Data Table on Market opportunity by Type ($ million)
Exhibit 64: Chart on Product Type - Market share 2025-2030 (%)
Exhibit 65: Data Table on Product Type - Market share 2025-2030 (%)
Exhibit 66: Chart on Comparison by Product Type
Exhibit 67: Data Table on Comparison by Product Type
Exhibit 68: Chart on Tablets - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Tablets - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Tablets - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Tablets - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Capsules - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Capsules - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Capsules - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Capsules - Year-over-year growth 2025-2030 (%)
Exhibit 76: Chart on Syrups - Market size and forecast 2025-2030 ($ million)
Exhibit 77: Data Table on Syrups - Market size and forecast 2025-2030 ($ million)
Exhibit 78: Chart on Syrups - Year-over-year growth 2025-2030 (%)
Exhibit 79: Data Table on Syrups - Year-over-year growth 2025-2030 (%)
Exhibit 80: Chart on Oral powders - Market size and forecast 2025-2030 ($ million)
Exhibit 81: Data Table on Oral powders - Market size and forecast 2025-2030 ($ million)
Exhibit 82: Chart on Oral powders - Year-over-year growth 2025-2030 (%)
Exhibit 83: Data Table on Oral powders - Year-over-year growth 2025-2030 (%)
Exhibit 84: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 85: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 86: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 87: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 88: Market opportunity by Product Type ($ million)
Exhibit 89: Data Table on Market opportunity by Product Type ($ million)
Exhibit 90: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 91: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 92: Chart on Comparison by Distribution Channel
Exhibit 93: Data Table on Comparison by Distribution Channel
Exhibit 94: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 98: Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 99: Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 101: Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 102: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 103: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 105: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 106: Market opportunity by Distribution Channel ($ million)
Exhibit 107: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 108: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 109: Chart on Market share by geography 2025-2030 (%)
Exhibit 110: Data Table on Market share by geography 2025-2030 (%)
Exhibit 111: Chart on Geographic comparison
Exhibit 112: Data Table on Geographic comparison
Exhibit 113: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 114: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 116: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 117: Chart on Regional Comparison - North America
Exhibit 118: Data Table on Regional Comparison - North America
Exhibit 119: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 129: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 130: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 131: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 132: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 133: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 134: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 135: Chart on Regional Comparison - Europe
Exhibit 136: Data Table on Regional Comparison - Europe
Exhibit 137: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 166: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 167: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 168: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 169: Chart on Regional Comparison - Asia
Exhibit 170: Data Table on Regional Comparison - Asia
Exhibit 171: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 200: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 201: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 204: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 205: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 229: Market opportunity by geography ($ million)
Exhibit 230: Data Tables on Market opportunity by geography ($ million)
Exhibit 231: Impact of drivers and challenges in 2025 and 2030
Exhibit 232: Overview on criticality of inputs and factors of differentiation
Exhibit 233: Overview on factors of disruption
Exhibit 234: Impact of key risks on business
Exhibit 235: Companies covered
Exhibit 236: Company ranking index
Exhibit 237: Matrix on companies position and classification
Exhibit 238: AbbVie Inc. - Overview
Exhibit 239: AbbVie Inc. - Business segments
Exhibit 240: AbbVie Inc. - Key news
Exhibit 241: AbbVie Inc. - Key offerings
Exhibit 242: AbbVie Inc. - Segment focus
Exhibit 243: SWOT
Exhibit 244: Astellas Pharma Inc. - Overview
Exhibit 245: Astellas Pharma Inc. - Product / Service
Exhibit 246: Astellas Pharma Inc. - Key news
Exhibit 247: Astellas Pharma Inc. - Key offerings
Exhibit 248: SWOT
Exhibit 249: AstraZeneca Plc - Overview
Exhibit 250: AstraZeneca Plc - Business segments
Exhibit 251: AstraZeneca Plc - Key news
Exhibit 252: AstraZeneca Plc - Key offerings
Exhibit 253: AstraZeneca Plc - Segment focus
Exhibit 254: SWOT
Exhibit 255: Bachem AG - Overview
Exhibit 256: Bachem AG - Business segments
Exhibit 257: Bachem AG - Key news
Exhibit 258: Bachem AG - Key offerings
Exhibit 259: Bachem AG - Segment focus
Exhibit 260: SWOT
Exhibit 261: Biocatalysts Ltd. - Overview
Exhibit 262: Biocatalysts Ltd. - Product / Service
Exhibit 263: Biocatalysts Ltd. - Key offerings
Exhibit 264: SWOT
Exhibit 265: Catalent Inc. - Overview
Exhibit 266: Catalent Inc. - Product / Service
Exhibit 267: Catalent Inc. - Key offerings
Exhibit 268: SWOT
Exhibit 269: Colorcon Inc. - Overview
Exhibit 270: Colorcon Inc. - Product / Service
Exhibit 271: Colorcon Inc. - Key offerings
Exhibit 272: SWOT
Exhibit 273: Corden Pharma Intl. GmbH - Overview
Exhibit 274: Corden Pharma Intl. GmbH - Product / Service
Exhibit 275: Corden Pharma Intl. GmbH - Key offerings
Exhibit 276: SWOT
Exhibit 277: Evonik Industries AG - Overview
Exhibit 278: Evonik Industries AG - Business segments
Exhibit 279: Evonik Industries AG - Key news
Exhibit 280: Evonik Industries AG - Key offerings
Exhibit 281: Evonik Industries AG - Segment focus
Exhibit 282: SWOT
Exhibit 283: Ironwood Pharmaceuticals Inc. - Overview
Exhibit 284: Ironwood Pharmaceuticals Inc. - Product / Service
Exhibit 285: Ironwood Pharmaceuticals Inc. - Key offerings
Exhibit 286: SWOT
Exhibit 287: Lonza Group Ltd. - Overview
Exhibit 288: Lonza Group Ltd. - Business segments
Exhibit 289: Lonza Group Ltd. - Key news
Exhibit 290: Lonza Group Ltd. - Key offerings
Exhibit 291: Lonza Group Ltd. - Segment focus
Exhibit 292: SWOT
Exhibit 293: Novo Nordisk AS - Overview
Exhibit 294: Novo Nordisk AS - Business segments
Exhibit 295: Novo Nordisk AS - Key offerings
Exhibit 296: Novo Nordisk AS - Segment focus
Exhibit 297: SWOT
Exhibit 298: Novozymes AS - Overview
Exhibit 299: Novozymes AS - Product / Service
Exhibit 300: Novozymes AS - Key offerings
Exhibit 301: SWOT
Exhibit 302: PolyPeptide Group - Overview
Exhibit 303: PolyPeptide Group - Product / Service
Exhibit 304: PolyPeptide Group - Key offerings
Exhibit 305: SWOT
Exhibit 306: Roquette Freres SA - Overview
Exhibit 307: Roquette Freres SA - Product / Service
Exhibit 308: Roquette Freres SA - Key offerings
Exhibit 309: SWOT
Exhibit 310: Inclusions checklist
Exhibit 311: Exclusions checklist
Exhibit 312: Currency conversion rates for US$
Exhibit 313: Research methodology
Exhibit 314: Information sources
Exhibit 315: Data validation
Exhibit 316: Validation techniques employed for market sizing
Exhibit 317: Data synthesis
Exhibit 318: 360 degree market analysis
Exhibit 319: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Product Type
Exhibit 7: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Oral Biologics Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Type - Market share 2025-2030 (%)
Exhibit 39: Data Table on Type - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Type
Exhibit 41: Data Table on Comparison by Type
Exhibit 42: Chart on GLP-1 receptor agonists - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on GLP-1 receptor agonists - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on GLP-1 receptor agonists - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on GLP-1 receptor agonists - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Hormones - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Hormones - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Hormones - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Hormones - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Recombinant enzymes - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Recombinant enzymes - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Recombinant enzymes - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Recombinant enzymes - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Somatostatin analogues - Market size and forecast 2025-2030 ($ million)
Exhibit 55: Data Table on Somatostatin analogues - Market size and forecast 2025-2030 ($ million)
Exhibit 56: Chart on Somatostatin analogues - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Somatostatin analogues - Year-over-year growth 2025-2030 (%)
Exhibit 58: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 59: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 60: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 62: Market opportunity by Type ($ million)
Exhibit 63: Data Table on Market opportunity by Type ($ million)
Exhibit 64: Chart on Product Type - Market share 2025-2030 (%)
Exhibit 65: Data Table on Product Type - Market share 2025-2030 (%)
Exhibit 66: Chart on Comparison by Product Type
Exhibit 67: Data Table on Comparison by Product Type
Exhibit 68: Chart on Tablets - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Tablets - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Tablets - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Tablets - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Capsules - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Capsules - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Capsules - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Capsules - Year-over-year growth 2025-2030 (%)
Exhibit 76: Chart on Syrups - Market size and forecast 2025-2030 ($ million)
Exhibit 77: Data Table on Syrups - Market size and forecast 2025-2030 ($ million)
Exhibit 78: Chart on Syrups - Year-over-year growth 2025-2030 (%)
Exhibit 79: Data Table on Syrups - Year-over-year growth 2025-2030 (%)
Exhibit 80: Chart on Oral powders - Market size and forecast 2025-2030 ($ million)
Exhibit 81: Data Table on Oral powders - Market size and forecast 2025-2030 ($ million)
Exhibit 82: Chart on Oral powders - Year-over-year growth 2025-2030 (%)
Exhibit 83: Data Table on Oral powders - Year-over-year growth 2025-2030 (%)
Exhibit 84: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 85: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 86: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 87: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 88: Market opportunity by Product Type ($ million)
Exhibit 89: Data Table on Market opportunity by Product Type ($ million)
Exhibit 90: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 91: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 92: Chart on Comparison by Distribution Channel
Exhibit 93: Data Table on Comparison by Distribution Channel
Exhibit 94: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 98: Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 99: Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 101: Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 102: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 103: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 105: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 106: Market opportunity by Distribution Channel ($ million)
Exhibit 107: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 108: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 109: Chart on Market share by geography 2025-2030 (%)
Exhibit 110: Data Table on Market share by geography 2025-2030 (%)
Exhibit 111: Chart on Geographic comparison
Exhibit 112: Data Table on Geographic comparison
Exhibit 113: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 114: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 116: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 117: Chart on Regional Comparison - North America
Exhibit 118: Data Table on Regional Comparison - North America
Exhibit 119: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 129: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 130: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 131: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 132: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 133: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 134: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 135: Chart on Regional Comparison - Europe
Exhibit 136: Data Table on Regional Comparison - Europe
Exhibit 137: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 166: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 167: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 168: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 169: Chart on Regional Comparison - Asia
Exhibit 170: Data Table on Regional Comparison - Asia
Exhibit 171: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 200: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 201: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 204: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 205: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 229: Market opportunity by geography ($ million)
Exhibit 230: Data Tables on Market opportunity by geography ($ million)
Exhibit 231: Impact of drivers and challenges in 2025 and 2030
Exhibit 232: Overview on criticality of inputs and factors of differentiation
Exhibit 233: Overview on factors of disruption
Exhibit 234: Impact of key risks on business
Exhibit 235: Companies covered
Exhibit 236: Company ranking index
Exhibit 237: Matrix on companies position and classification
Exhibit 238: AbbVie Inc. - Overview
Exhibit 239: AbbVie Inc. - Business segments
Exhibit 240: AbbVie Inc. - Key news
Exhibit 241: AbbVie Inc. - Key offerings
Exhibit 242: AbbVie Inc. - Segment focus
Exhibit 243: SWOT
Exhibit 244: Astellas Pharma Inc. - Overview
Exhibit 245: Astellas Pharma Inc. - Product / Service
Exhibit 246: Astellas Pharma Inc. - Key news
Exhibit 247: Astellas Pharma Inc. - Key offerings
Exhibit 248: SWOT
Exhibit 249: AstraZeneca Plc - Overview
Exhibit 250: AstraZeneca Plc - Business segments
Exhibit 251: AstraZeneca Plc - Key news
Exhibit 252: AstraZeneca Plc - Key offerings
Exhibit 253: AstraZeneca Plc - Segment focus
Exhibit 254: SWOT
Exhibit 255: Bachem AG - Overview
Exhibit 256: Bachem AG - Business segments
Exhibit 257: Bachem AG - Key news
Exhibit 258: Bachem AG - Key offerings
Exhibit 259: Bachem AG - Segment focus
Exhibit 260: SWOT
Exhibit 261: Biocatalysts Ltd. - Overview
Exhibit 262: Biocatalysts Ltd. - Product / Service
Exhibit 263: Biocatalysts Ltd. - Key offerings
Exhibit 264: SWOT
Exhibit 265: Catalent Inc. - Overview
Exhibit 266: Catalent Inc. - Product / Service
Exhibit 267: Catalent Inc. - Key offerings
Exhibit 268: SWOT
Exhibit 269: Colorcon Inc. - Overview
Exhibit 270: Colorcon Inc. - Product / Service
Exhibit 271: Colorcon Inc. - Key offerings
Exhibit 272: SWOT
Exhibit 273: Corden Pharma Intl. GmbH - Overview
Exhibit 274: Corden Pharma Intl. GmbH - Product / Service
Exhibit 275: Corden Pharma Intl. GmbH - Key offerings
Exhibit 276: SWOT
Exhibit 277: Evonik Industries AG - Overview
Exhibit 278: Evonik Industries AG - Business segments
Exhibit 279: Evonik Industries AG - Key news
Exhibit 280: Evonik Industries AG - Key offerings
Exhibit 281: Evonik Industries AG - Segment focus
Exhibit 282: SWOT
Exhibit 283: Ironwood Pharmaceuticals Inc. - Overview
Exhibit 284: Ironwood Pharmaceuticals Inc. - Product / Service
Exhibit 285: Ironwood Pharmaceuticals Inc. - Key offerings
Exhibit 286: SWOT
Exhibit 287: Lonza Group Ltd. - Overview
Exhibit 288: Lonza Group Ltd. - Business segments
Exhibit 289: Lonza Group Ltd. - Key news
Exhibit 290: Lonza Group Ltd. - Key offerings
Exhibit 291: Lonza Group Ltd. - Segment focus
Exhibit 292: SWOT
Exhibit 293: Novo Nordisk AS - Overview
Exhibit 294: Novo Nordisk AS - Business segments
Exhibit 295: Novo Nordisk AS - Key offerings
Exhibit 296: Novo Nordisk AS - Segment focus
Exhibit 297: SWOT
Exhibit 298: Novozymes AS - Overview
Exhibit 299: Novozymes AS - Product / Service
Exhibit 300: Novozymes AS - Key offerings
Exhibit 301: SWOT
Exhibit 302: PolyPeptide Group - Overview
Exhibit 303: PolyPeptide Group - Product / Service
Exhibit 304: PolyPeptide Group - Key offerings
Exhibit 305: SWOT
Exhibit 306: Roquette Freres SA - Overview
Exhibit 307: Roquette Freres SA - Product / Service
Exhibit 308: Roquette Freres SA - Key offerings
Exhibit 309: SWOT
Exhibit 310: Inclusions checklist
Exhibit 311: Exclusions checklist
Exhibit 312: Currency conversion rates for US$
Exhibit 313: Research methodology
Exhibit 314: Information sources
Exhibit 315: Data validation
Exhibit 316: Validation techniques employed for market sizing
Exhibit 317: Data synthesis
Exhibit 318: 360 degree market analysis
Exhibit 319: List of abbreviations
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Astellas Pharma Inc.
- AstraZeneca Plc
- Bachem AG
- Bausch Health Co Inc.
- Biocatalysts Ltd.
- Catalent Inc.
- Colorcon Inc.
- Corden Pharma Intl. GmbH
- Evonik Industries AG
- Ironwood Pharmaceuticals Inc.
- Lonza Group Ltd.
- Nestle Health Science S.A.
- Novo Nordisk AS
- Novozymes AS
- PolyPeptide Group
- Roquette Freres SA
- Viatris Inc.
- VIVUS LLC
